Clinical trials
Breast Neoplasms trials in Slovakia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 5 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Active, not recruiting | 14 |
| Terminated | 4 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Approved for marketing | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 10 |
| Pfizer | 10 |
| Novartis Pharmaceuticals | 5 |
| AstraZeneca | 4 |
| Central European Cooperative Oncology Group | 3 |
| Comenius University | 3 |
| Eli Lilly and Company | 3 |
| Sanofi | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| GlaxoSmithKline | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 61 |
| Neoplasm Metastasis | 5 |
| Neoplasms | 5 |
| Recurrence | 4 |
| Blast Crisis | 2 |
| Breast Diseases | 2 |
| Burkitt Lymphoma | 2 |
| Carcinoma, Ovarian Epithelial | 2 |
| Colorectal Neoplasms | 2 |
| Hodgkin Disease | 2 |
Trials
Showing 51 to 61 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.